Business Segments · Cost of revenue

Business Segments — Cost of revenue

Guardant Health Business Segments — Cost of revenue increased by 11.8% to $101.56M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 40.7%, from $72.19M to $101.56M. This increase may warrant attention — for this metric, lower values are generally preferred.

Analysis

StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityModerate
First reportedQ1 2024
Last reportedQ1 2026May 7, 2026

How to read this metric

A decrease relative to revenue indicates improved operational efficiency and better margins, while an increase may suggest rising production costs or supply chain inefficiencies.

Detailed definition

This metric captures the direct costs associated with producing and delivering the diagnostic tests and services sold by...

Peer comparison

Commonly referred to as Cost of Goods Sold (COGS) in manufacturing and diagnostic service industries.

Metric ID: gh_segment_reportable_segment_cost_of_revenue

Historical Data

7 periods
 Q1 '24Q2 '24Q3 '24Q1 '25Q2 '25Q3 '25Q1 '26
Value$63.17M$70.40M$70.42M$72.19M$78.30M$90.87M$101.56M
QoQ Change+11.4%+0.0%+2.5%+8.5%+16.1%+11.8%
YoY Change+14.3%+11.2%+29.0%+40.7%
Range$63.17M$101.56M
CAGR+37.2%
Avg YoY Growth+23.8%
Median YoY Growth+21.7%
Current Streak6+ quarters growth

Frequently Asked Questions

What is Guardant Health's business segments — cost of revenue?
Guardant Health (GH) reported business segments — cost of revenue of $101.56M in Q1 2026.
How has Guardant Health's business segments — cost of revenue changed year-over-year?
Guardant Health's business segments — cost of revenue increased by 40.7% year-over-year, from $72.19M to $101.56M.
What does business segments — cost of revenue mean?
The direct costs incurred to produce and deliver the company's products and services.